AbbVie Inc. (ABBV) Social Stream
ABBVIE INC (ABBV) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering ABBV.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-01 | 13 | $140 | $118 | $128 | $163.78 | -21.85% |
| 2021-11-23 | 12 | $172 | $118 | $131.666 | $163.78 | -19.61% |
| 2022-01-03 | 13 | $172 | $118 | $137.923 | $163.78 | -15.79% |
| 2022-01-05 | 13 | $172 | $118 | $140.923 | $163.78 | -13.96% |
| 2022-01-14 | 13 | $172 | $118 | $143.416 | $163.78 | -12.43% |
| 2022-01-19 | 13 | $172 | $118 | $147.166 | $163.78 | -10.14% |
| 2022-02-01 | 13 | $172 | $133 | $149.916 | $163.78 | -8.47% |
| 2022-02-03 | 13 | $180 | $133 | $151.416 | $163.78 | -7.55% |
| 2022-02-14 | 13 | $180 | $133 | $153.5 | $163.78 | -6.28% |
| 2022-02-17 | 13 | $180 | $133 | $154.083 | $163.78 | -5.92% |
| 2022-03-08 | 14 | $180 | $133 | $153.538 | $163.78 | -6.25% |
| 2022-03-16 | 14 | $180 | $133 | $154.076 | $163.78 | -5.93% |
| 2022-04-06 | 13 | $192 | $133 | $159.833 | $163.78 | -2.41% |
| 2022-04-13 | 12 | $192 | $147 | $163.25 | $163.78 | -0.32% |
| 2022-04-18 | 13 | $192 | $147 | $163.25 | $163.78 | -0.32% |
| 2022-04-22 | 13 | $192 | $147 | $166.083 | $163.78 | 1.41% |
| 2022-04-29 | 13 | $192 | $147 | $167.833 | $163.78 | 2.47% |
| 2022-05-02 | 13 | $200 | $147 | $170.416 | $163.78 | 4.05% |
| 2022-05-11 | 13 | $200 | $147 | $168.846 | $163.78 | 3.09% |
| 2022-05-20 | 14 | $200 | $140 | $166.785 | $163.78 | 1.83% |
| 2022-06-09 | 15 | $200 | $140 | $165 | $163.78 | 0.74% |
| 2022-07-22 | 15 | $200 | $140 | $165.2 | $163.78 | 0.87% |
| 2022-07-29 | 14 | $200 | $140 | $165.2 | $163.78 | 0.87% |
| 2022-08-01 | 16 | $200 | $140 | $165 | $163.78 | 0.74% |
| 2022-08-24 | 15 | $200 | $140 | $163.562 | $163.78 | -0.13% |
| 2022-09-21 | 16 | $200 | $140 | $163.562 | $163.78 | -0.13% |
| 2022-10-03 | 16 | $200 | $135 | $163.25 | $163.78 | -0.32% |
| 2022-10-12 | 16 | $200 | $135 | $163.062 | $163.78 | -0.44% |
| 2022-10-28 | 16 | $200 | $135 | $163.312 | $163.78 | -0.29% |
| 2022-10-31 | 16 | $200 | $135 | $162.25 | $163.78 | -0.93% |
| 2022-11-01 | 16 | $200 | $135 | $161.937 | $163.78 | -1.13% |
| 2022-12-04 | 16 | $200 | $135 | $161.266 | $163.78 | -1.53% |
| 2022-12-05 | 16 | $200 | $135 | $161.4 | $163.78 | -1.45% |
| 2022-12-06 | 16 | $200 | $135 | $161.666 | $163.78 | -1.29% |
| 2022-12-13 | 15 | $200 | $135 | $161.866 | $163.78 | -1.17% |
| 2023-01-04 | 15 | $200 | $135 | $162.533 | $163.78 | -0.76% |
| 2023-01-11 | 15 | $200 | $135 | $164.571 | $163.78 | 0.48% |
| 2023-01-27 | 15 | $200 | $135 | $164.714 | $163.78 | 0.57% |
| 2023-02-08 | 15 | $200 | $135 | $164.357 | $163.78 | 0.35% |
| 2023-02-09 | 15 | $200 | $135 | $164.571 | $163.78 | 0.48% |
| 2023-02-13 | 15 | $200 | $140 | $166 | $163.78 | 1.36% |
| 2023-03-31 | 16 | $200 | $140 | $165.733 | $163.78 | 1.19% |
| 2023-04-10 | 16 | $200 | $140 | $165.933 | $163.78 | 1.31% |
| 2023-04-26 | 15 | $200 | $146 | $168.142 | $163.78 | 2.66% |
| 2023-04-28 | 16 | $195 | $146 | $167.714 | $163.78 | 2.4% |
| 2023-05-05 | 16 | $195 | $146 | $167.785 | $163.78 | 2.45% |
| 2023-07-11 | 16 | $195 | $146 | $169.153 | $163.78 | 3.28% |
| 2023-07-18 | 16 | $195 | $146 | $169 | $163.78 | 3.19% |
| 2023-07-24 | 16 | $195 | $146 | $170.214 | $163.78 | 3.93% |
| 2023-07-28 | 17 | $195 | $146 | $170.214 | $163.78 | 3.93% |
| 2023-09-06 | 16 | $195 | $154 | $173.307 | $163.78 | 5.82% |
| 2023-09-29 | 17 | $195 | $154 | $173.307 | $163.78 | 5.82% |
| 2023-10-09 | 17 | $195 | $154 | $173.571 | $163.78 | 5.98% |
| 2023-10-17 | 17 | $195 | $154 | $173.857 | $163.78 | 6.15% |
| 2023-10-25 | 16 | $195 | $154 | $173.857 | $163.78 | 6.15% |
| 2023-10-27 | 17 | $195 | $150 | $172.266 | $163.78 | 5.18% |
| 2023-10-30 | 17 | $196 | $150 | $173.266 | $163.78 | 5.79% |
| 2023-11-29 | 18 | $196 | $150 | $171.812 | $163.78 | 4.9% |
| 2023-12-01 | 18 | $196 | $150 | $171.937 | $163.78 | 4.98% |
| 2023-12-08 | 19 | $196 | $147 | $170.705 | $163.78 | 4.23% |
| 2023-12-11 | 19 | $196 | $147 | $171 | $163.78 | 4.41% |
| 2023-12-12 | 19 | $196 | $150 | $172.529 | $163.78 | 5.34% |
| 2023-12-29 | 19 | $197 | $150 | $172.588 | $163.78 | 5.38% |
The Trend in the Analyst Price Target
Over the past 49 weeks, ABBV's average price target has gone up $7.87.
ABBV reports an average of 15.77% for its upside potential over the past 49 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-04-28 | 16 | 195 | 146 | 167.785 | 151.12 | 11.03% |
| 2023-05-05 | 16 | 195 | 146 | 167.785 | 148.03 | 13.35% |
| 2023-05-22 | 16 | 195 | 146 | 169.153 | 144.90 | 16.74% |
| 2023-09-06 | 16 | 195 | 154 | 173.307 | 145.61 | 19.02% |
| 2023-11-10 | 18 | 196 | 150 | 171.812 | 138.59 | 23.97% |
ABBV Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.92 | 9 | 2 | 8 | 0 | 0 | 19 |
The Trend in the Broker Recommendations
ABBV's average broker recommendation rating improved by 0.18 over the prior 35 weeks.
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- ABBV has a greater average analyst price target than 6911.45% of Pharmaceutical Products stocks.
- ABBV has a higher upside potential (average analyst target price relative to current price) than 1025.14% of Pharmaceutical Products stocks.
- ABBV has a higher number of analysts covering the stock than 6571.47% of Pharmaceutical Products stocks.
- In the context of Pharmaceutical Products stocks, ABBVIE INC's variance in analysts' estimates is lower than -1282.06% of them.
In the Pharmaceutical Products industry, MRK, JNJ, and PFE are the three stocks most similar to ABBVIE INC regarding the price target and analyst recommendation information presented here.
View All Top Stocks by Price Target
Is ABBV a Buy, Hold or Sell? See the POWR Ratings now!